Question from Kelly- 60 posts, can we assign to categories? keep other languages?
The New Age of Alzheimer’s (Links to an external site)
The Knight Family DIAN-TU Amyloid Removal Trial
Update to the 18 August 2023 announcement by the Knight Family DIAN-TU)regarding the DIAN-TU-001 Open Label Extension (OLE) Study
Encouraging findings in Alzheimer’s prevention trial lead to the next phase (Links to an external site)
Importante estudio en enfermedad de Alzheimer abrirá 5 nuevos sitios latinoamericanos (Links to an external site)
Woman facing Alzheimer’s head on (Links to an external site)
Early Alzheimer’s families hold key to beating dementia (Links to an external site)
Cerveau Technologies, Inc. Announces a Partnership with Landmark Alzheimer’s Disease DIAN-TU Trial (Links to an external site)
Jetske en Jeroen zijn dragers van het Alzheimer-gen (Links to an external site)
A family with an astonishing rate of Alzheimer’s disease may harbor a powerful new gene (Links to an external site)
Three generations of a British family are helping the fight against Alzheimer’s (Links to an external site)
Two new drugs being studied at Wash U study could help Alzheimer’s patients (Links to an external site)
The fight against Alzheimer’s: ‘Every Minute Counts’ reveals latest developments (Links to an external site)
Alzheimer’s disease affects more than 5 million Americans. Neurologist Dr. Rudy Tanzi and Daisy Duarte, whose mother is in the final stages of Alzheimer’s, talk to Kathie Lee Gifford and Jenna Bush Hager about the new PBS documentary “Every Minute Counts,” which reveals the latest developments in the fight against the devastating illness.
The New Offensive on Alzheimer’s disease: Stop it before it Starts (Links to an external site)
WashU early AD initiative could yield broader clues (Links to an external site)
If intervening ahead of symptoms in Alzheimer’s disease (AD) works in people with gene mutations that predispose them to getting sick at a younger age, then it will probably work in the rest of the population, principal investigator Randall Bateman theorized to BioWorld Today, and his team at Washington University (WashU) – testing drugs provided […]
Early Alzheimer’s Gene Is A Curse For Families, A Gift For Science (Links to an external site)
Landmark Alzheimer’s prevention trial to evaluate third drug (Links to an external site)
An international study to test drugs that may prevent or delay Alzheimer’s disease is adding a third drug arm. Participants who receive the drug or placebo will be monitored for at least four years for signs of the disease.
The Alzheimer’s Laboratory (Links to an external site)
A changing landscape: Alzheimer’s disease, research and the future of care (Links to an external site)
Ongoing international research led by Washington University investigators is changing the Alzheimer’s disease landscape from hopeless to hopeful.
Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial (Links to an external site)
An experimental Alzheimer’s drug that had previously appeared to show promise in slowing the deterioration of thinking and memory has failed in a large Eli Lilly clinical trial, dealing a significant disappointment to patients hoping for a treatment that would alleviate their symptoms.
Dominantly Inherited Alzheimer Network Trial (DIAN-TU-001) continues despite results from Eli Lilly and Company’s EXPEDITION3 trial (Links to an external site)
German Families with Dominantly Inherited Alzheimer’s Disease Meet for the First Time (Links to an external site)
Nobody knew each other’s name. Even so, 60 people who either were at risk of having an autosomal-dominant Alzheimer’s mutation, or were accompanying someone who was, exchanged information about a shared problem. There were moments of validation—“Denial has divided my family, too!”—and apprehensive questions—“Do you want to know if you have it?”
Why Most Alzheimer’s Research Is Done On Early-Onset Patients Like Pat Summitt (Links to an external site)
$4 million grant expands major study to find Alzheimer’s prevention treatments (Links to an external site)
Washington University School of Medicine in St. Louis has received a $4.3 million award from the Alzheimer’s Association to expand a major international clinical trial evaluating whether drugs can prevent Alzheimer’s disease in patients genetically predisposed to develop the devastating disease at a young age.
Family places hope in drug trial for hereditary Alzheimer’s gene mutation (Links to an external site)
Alzheimer’s Disease: Daisy’s Story (Links to an external site)
Man looking for answers with new Alzheimer’s study (Links to an external site)
He has the disease and he’s lost five family members to it, now he’s enrolled in a study hoping to find some answers in Alzheimer’s disease.
Trial aims to prevent Alzheimer’s in those genetically predisposed (Links to an external site)
A first-of-its-kind study is testing the use of antibody drugs to prevent or slow down the onset of Alzheimer’s disease in individuals genetically destined to develop the illness at an early age.
Screening for Alzheimer’s Gene Tests the Desire to Know (Links to an external site)
The Hardest Test: Tucson family has hereditary Alzheimer’s (Links to an external site)
Dominantly Inherited Alzheimer’s Network-Trials Unit on PBS (Links to an external site)
Brian and Amelia Cottle’s story: Living with early onset Alzheimer’s disease (Links to an external site)
Dominantly Inherited Alzheimer Network Trial Completes Participant Enrollment for Two Drugs in Phase II/III Study of Amyloid Therapies (Links to an external site)
First trial to stop Alzheimer’s before symptoms emerge (Links to an external site)
Most research into dementia is about finding treatments for people who are already affected by symptoms. But a trial is under way in London which aims to prevent Alzheimer’s in people at high risk, before they show any physical signs of the disease.
Family with history of rare Alzheimer’s gene hopes for a cure (Links to an external site)
Can knowing you and your family may get Alzheimer’s ever be positive? (Links to an external site)
At the University of Washington’s School of Medicine there is a computer database that states with certainty – albeit heavily encrypted – whether or not Sophie Leggett will develop a form of genetically inherited early onset Alzheimer’s disease. But she has chosen not to find out what it says.
Slipping Away (Links to an external site)
Alzheimer’s: Experimental drug offers hope to families with legacy of degenerative brain disease (Links to an external site)
Alzheimer’s Association International Conference 2015: ADAD Family Conference (Links to an external site)
Families Affected by Early Alzheimer’s Seek Better Treatment (Links to an external site)
Younger Adults with Alzheimer’s are Key to Drug Research (Links to an external site)
Fast-Forwarding Treatment for Neurodegenerative Disorders (Links to an external site)
Researchers at the Leonard Wolfson Experimental Neurology Centre in London, UK, want to accelerate early-stage treatment trials for neurodegenerative disorders. Dara Mohammadi speaks to the investigators about the need to stimulate drug discovery.
Why a Woman in her 30s Decided to Find Out If She Will Get Alzheimer’s (Links to an external site)
Reason To Hope: Thank You (Video) (Links to an external site)
NHK Special: “Stop Alzheimer’s Disease!” won Takayanagi Prize (Links to an external site)
In a New Approach to Fighting Disease, Helpful Genetic Mutations Are Sought (Links to an external site)
New funding speeds identification of drugs to prevent Alzheimer’s (Links to an external site)
Reclaiming the future for those affected by Alzheimer’s (Links to an external site)
Over 150 people in Montgomery are set to gather this weekend to reclaim the future for the five millions Americans suffering from Alzheimer’s. For two women in the River Region, the disease has directly impacted their lives and they’re leading the fight for a cure.
Preventing Alzheimer’s (Links to an external site)
Finding ways to diagnose and treat this devastating disease has frustrated scientists and clinicians ever since. Now the long and hard-fought campaign against Alzheimer’s has reached a potentially significant milestone: the launch of the first clinical trials to test whether new drug treatments given before dementia can prevent the disease.
Multicompany trials adapt to disciplines beyond cancer (Links to an external site)
Trials at Washington U. medical school offer hope for Alzheimer’s treatment (Links to an external site)
Unraveling Alzheimer’s mysteries in search of new treatment (Links to an external site)
Over the past several decades scientists have begun to unravel the complicated process that leads to the death of brain cells and, ultimately, the disease we call Alzheimer’s. That new understanding may lead to therapies that can halt the disease before symptoms appear and brains are irreparably damaged.
In Familial AD, Aß Production Up, Clearance Down (Links to an external site)
Researchers have long assumed that people with familial Alzheimer’s disease make too much Aβ42 in the brain, but they lacked proof. Now, in the June 12 Science Translational Medicine, researchers led by Randall Bateman at Washington University in St. Louis, Missouri, provide the first direct evidence.
Innovations: Alzheimer’s Disease: New Hope in Scientific Studies (Links to an external site)
Could there possibly be a cure for Alzheimer’s disease in the future? Through the current DIAN Network Study and Drug Trials headquartered at Washington University in St. Louis, early detection and prevention could become a reality. Dr. Randall Bateman, Charles F. and Joanne Knight Distinguished Professor in Neurology Washington University School of Medicine in St. […]
Study to find possible Alzheimer’s breakthrough (Links to an external site)
The urgent need for better treatment of Alzheimer ‘s disease and other kinds of dementia was highlighted this past week with a report that said dementia cost this country as much as $215 billion a year. well, now there is a fascinating study going on involving some new drugs that might prevent Alzheimer ‘s. we […]
Washington University Researchers Hope Drug Cures Alzheimer’s Disease (Links to an external site)
Very few people carry that mutation, but enough have it for Washington University researchers to test three drugs that could offer hope for them, and the larger search for a cure.
Stopping Alzheimer’s Before It Starts (Links to an external site)
Three new clinical trials expected to begin next year will attempt to prevent dementia by treating people at risk for the disease before they develop symptoms.
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (Links to an external site)
First detailed timeline established for brain’s descent into Alzheimer’s (Links to an external site)
Scientists have assembled the most detailed chronology to date of the human brain’s long, slow slide into full-blown Alzheimer’s disease.
Predicting the Course of Alzheimer’s (Links to an external site)
An Alzheimer’s Gene – One Family’s Saga (Links to an external site)
